Science news and discoveries from Mass General Brigham
Bench PressBench PressBench PressBench Press
  • Home
  • About Us
  • Research
    • Brain Research
    • Heart
    • Cancer
    • More…

Mass General Research Roundup for April 2019

    Home Psychiatry Addiction & Substance Use Disorder Mass General Research Roundup for April 2019

    Mass General Research Roundup for April 2019

    By mghresearch | Addiction & Substance Use Disorder, Research Roundup | 0 comment | 16 April, 2019 | 0

    Research Roundup is a brief recap of recent research news from investigators at Massachusetts General Hospital.

    Chronic Health Problems Common After Addiction Recovery

    Investigators from Massachusetts General Hospital’s Recovery Research Institute found that a third of individuals in recovery from substance use disorder continue to suffer from chronic physical diseases that have been exacerbated by their substance use.

    In a study of 2,000 individuals in recovery from drug or alcohol use disorders, researchers found 37 percent had been diagnosed with one or more of nine alcohol- and drug-exacerbated diseases and health conditions: liver disease, tuberculosis (TB), HIV/AIDS or other sexually transmitted infections (STIs), cancer, hepatitis C, chronic obstructive pulmonary disease (COPD), heart disease and diabetes.

    The presence of these diseases was shown to be associated with significant reductions in participants’ quality of life, and all are known to reduce life expectancy.

    “Earlier and more assertive intervention is needed for individuals with alcohol and other drug problems to help prevent these other diseases,” says David Eddie, PhD, the lead author of the study.

    “In addition, addiction treatment needs to be more seamlessly integrated with primary health care, and more research is needed to explore the complex relationships between alcohol and other drug use and physical disease.”


    Oxytocin Weakens the Brain’s Reward Signals for Food

    Previous research studies have shown that oxytocin—a naturally occurring hormone that is known for promoting bonding—acts on brain pathways related to eating behavior and may be a promising treatment for obesity. But how exactly does it work?

    Researchers from Mass General’s Department of Endocrinology found that oxytocin reduces the communication between different brain areas involved in the cognitive, sensory and emotional processing of food cues that people with obesity demonstrate when they look at high-calorie foods.

    “Knowing how the drug exerts its effects is a critical step toward establishing oxytocin as a drug treatment for overeating and obesity,” said the study’s lead investigator, Liya Kerem, MD, MSc.


    Older Women Benefit Significantly When Screened with 3-D Mammography

    Breast cancer is the most common cancer and the second most common cause of death from cancer among women in the United States.

    In the new study, researchers at Massachusetts General Hospital (MGH) sought to learn more about the performance of 2D mammography and 3D mammography in older women (mean age of 72 years).

    They compared screening mammograms from more than 15,000 women who underwent 2D mammography with those of more than 20,000 women who underwent the 3D screening.

    Both approaches were highly effective at detecting cancer, but 3D mammography had some advantages over the 2D approach, including a reduction in false-positive examinations.

    3D screenings also had a higher positive predictive value, the probability that women with a positive screening result will have breast cancer, and higher specificity, or the ability to distinguish cancer from benign findings.

    “We’ve shown that screening mammography performs well in older women, with high cancer detection rates and low false-positives, and that tomosynthesis (3D screening) leads to even better performance than conventional 2D mammography,” said study lead author Manisha Bahl, MD, MPH.


    About the Mass General Research Institute
    Research at Massachusetts General Hospital is interwoven through more than 30 different departments, centers and institutes. Our research includes fundamental, lab-based science; clinical trials to test new drugs, devices and diagnostic tools; and community and population-based research to improve health outcomes across populations and eliminate disparities in care.
    Support our Research

    No tags.

    Leave a Comment

    Cancel reply

    Your email address will not be published. Required fields are marked *

    • About
    • About Us
    • Brain Research
    • Cancer
    • Communicating Science
    • Contenido en español
    • COVID-19
    • Events
    • Heart
    • History
    • Home (OLD)
      • Disclaimer
      • Home
    • Just kidding!
    • MGH Chief Academic Officer Job Description
    • MGRI Image Awards
    • MGRI Image Awards
    • MGRI Science Communications Intern
    • Research
    • Research News Funding Opportunities
    • Research News: Announcements & Events
    • Science Slam Tips and Tricks
    • Subscribe
    Bench Press